Localization of Glycerol‐3‐Phosphate Oxidase in the Mitochondrion and Particulate NAD+‐Linked Glycerol‐3‐Phosphate Dehydrogenase in the Microbodies of the Bloodstream Form of Trypanosoma brucei
Abstract:We have studied the intracellular location of glycerol-3-phosphate oxidase and NAD+-linked glycerol-3-phosphate dehydrogenase, two enzymes involved in the very active dihydroxyacetone phosphate : glycerol-3-phosphate cycle in Trypanosoma brucei. Isopycnic centrifugation of a largegranule fraction resulted in a 10-20-fold purification of the oxidase and showed that the enzyme behaved like the mitochondrial ATPase, isocitrate dehydrogenase and the particulate malate dehydrogenase. The activity profiles of these … Show more
“…The histogram shows no predominant length classes and all molecules present could represent the degradation products of nuclear DNA or kinetoplast DNA. Several methods have been described for the purification of glycosomes from Trypanosoma brucei (4,21,40). One utilized isopycnic centrifugation of a large-particle preparation in a linear sucrose gradient, where glycosomes equilibrate at a density of 1 .23 g/cm' .…”
Section: Dna In Glycosome Preparationsmentioning
confidence: 99%
“…Since the discovery of these organelles in Trypanosoma brucei (1), they have been found in all major representatives of this family (i.e., T. cruzi (2), Leishmania mexicana (3) and several Crithidia spp. (2,(4)(5)(6)). The glycosomes in T. brucei contain at least nine enzymes involved in or related to glycolysis, which can account for the conversion of glucose to 3-phosphoglycerate plus glycerol.…”
Trypanosoma brucei glycosomes (microbodies containing nine enzymes involved in glycolysis) have been purified to near homogeneity from bloodstream-form trypomastigotes for the purpose of morphologic and biochemical analysis . Differential centrifugation followed by two isopycnic centrifugations in an isotonic Percoll and in a sucrose gradient, respectively, resulted in 12-to 13-fold purified glycosomes with an overall yield of 31% . These glycosomes appeared to be highly pure and contained <1% mitochondrial contamination as judged by morphometric and biochemical analyses. In intact cells, glycosomes displayed a remarkably homogeneous size distribution centered on an average diameter of 0.27 um with a standard deviation of 0.03 um . The size distribution of isolated glycosomes differed only slightly from that measured in intact cells. One T. brucei cell contained on average 230 glycosomes, representing 4.3% of the total cell volume . The glycosomes were surrounded by a single membrane and contained as phospholipids only phosphatidyl choline and phosphatidyl ethanolamine in a ratio of 2:1 . The purified glycosomal fraction had a very low DNA content of 0.18 hg/mg protein . No DNA molecules were observed that could not have been derived from contaminating mitochondrial or nuclear debris.
“…The histogram shows no predominant length classes and all molecules present could represent the degradation products of nuclear DNA or kinetoplast DNA. Several methods have been described for the purification of glycosomes from Trypanosoma brucei (4,21,40). One utilized isopycnic centrifugation of a large-particle preparation in a linear sucrose gradient, where glycosomes equilibrate at a density of 1 .23 g/cm' .…”
Section: Dna In Glycosome Preparationsmentioning
confidence: 99%
“…Since the discovery of these organelles in Trypanosoma brucei (1), they have been found in all major representatives of this family (i.e., T. cruzi (2), Leishmania mexicana (3) and several Crithidia spp. (2,(4)(5)(6)). The glycosomes in T. brucei contain at least nine enzymes involved in or related to glycolysis, which can account for the conversion of glucose to 3-phosphoglycerate plus glycerol.…”
Trypanosoma brucei glycosomes (microbodies containing nine enzymes involved in glycolysis) have been purified to near homogeneity from bloodstream-form trypomastigotes for the purpose of morphologic and biochemical analysis . Differential centrifugation followed by two isopycnic centrifugations in an isotonic Percoll and in a sucrose gradient, respectively, resulted in 12-to 13-fold purified glycosomes with an overall yield of 31% . These glycosomes appeared to be highly pure and contained <1% mitochondrial contamination as judged by morphometric and biochemical analyses. In intact cells, glycosomes displayed a remarkably homogeneous size distribution centered on an average diameter of 0.27 um with a standard deviation of 0.03 um . The size distribution of isolated glycosomes differed only slightly from that measured in intact cells. One T. brucei cell contained on average 230 glycosomes, representing 4.3% of the total cell volume . The glycosomes were surrounded by a single membrane and contained as phospholipids only phosphatidyl choline and phosphatidyl ethanolamine in a ratio of 2:1 . The purified glycosomal fraction had a very low DNA content of 0.18 hg/mg protein . No DNA molecules were observed that could not have been derived from contaminating mitochondrial or nuclear debris.
“…In bloodstream forms glucose is degraded solely by glycolysis to form two mol pyruvate/mol glucose. Reducing equivalents are transferred to oxygen via a unique mitochondrial glycerol-3-phosphate oxidase [17,18]. The promitochondrion lacks a functional citric acid cycle as well as a cytochrome-linked respiratory chain.…”
Monomorphic bloodstream forms of Trypanosoma brucei, grown in the mammal, are deficient in aconitase and 2-oxoglutarate dehydrogenase and they do not respire in the presence of the substrates citrate, cis-aconitate, succinate, proline or 2-oxoglutarate. When grown in vitro low levels of aconitase, succinate oxidase and proline oxidase are detected.Addition of citratelcis-aconitate at 37 "C to bloodstream forms leads to the formation of aconitase and proline oxidase. Most cells undergo an 'abortive' transformation to non-dividing procyclic-like cells while some cells adapt to the presence of the citric acid cycle intermediates and continue to multiply as bloodstream forms.At 27°C and in the presence of citratelcis-aconitate bloodstream forms transform synchronously to dividing procyclic cells. Within 72 h the rate of respiration with proline, succinate and 2-oxoglutarate becomes similar to that in established procyclic cells while the rate of glucose oxidation decreases.The possible role of citric acid cycle intermediates in determining whether a trypanosome will retain the properties of a bloodstream trypomastigote or differentiate to a procyclic trypomastigote is discussed.The parasitic protozoan, Trypanosoma brucei, undergoes a series of differentiation steps during its cyclical development in the mammalian host and the arthropod vector, the tsetse fly [l]. Differentiation of bloodstream forms to procyclic cells, a process called transformation, is initiated in the mammal by the transition of dividing slender forms to intermediate and non-dividing stumpy forms, giving rise to a pleomorphic population. After uptake with the blood meal into the midgut of the fly, cells with stumpy morphology are considered to transform most readily to dividing procyclic cells.Transformation of pleomorphic as well as monomorphic populations of rodent-adapted strains which have a uniform slender morphology [2] can be studied in various in vitro systems [3 -91. Synchronous transformation requires two external signals, a temperature change from 37°C to 27°C and the addition of cis-aconitate and/or citrate as inducers Some of the complex morphological, ultrastructural and metabolic changes which characterize transformation have been studied in detail. First, the repression of the synthesis of the variant surface glycoprotein (VSG) in the coated bloodstream forms is an early event which is followed by coat [lo-131. release to form coatless procyclic cells [7, 8, 111. Second, transformation involves profound changes in energy metabolism [14-161. In bloodstream forms glucose is degraded solely by glycolysis to form two mol pyruvate/mol glucose. Reducing equivalents are transferred to oxygen via a unique mitochondrial glycerol-3-phosphate oxidase [17,18]. The promitochondrion lacks a functional citric acid cycle as well as a cytochrome-linked respiratory chain. Stumpy forms contain some mitochondrial enzymes, such as 2-oxoglutarate dehydrogenase and proline oxidase [19]. During transformation to procyclic cells a functional respiratory ...
“…Glucose is metabolized only as far as pyruvate (20); the NAD reduced during glycolysis is regenerated in microbodies by the reduction of dihydroxyacetone phosphate (19,20). The aGP formed is in turn recycled by an oxidase complex which is associated with a rudimentary mitochondria (21). Most of the electrons from the oxidation of aGP are incorporated into water.…”
Section: Assessment Of Trypanocidal Activity In Vivomentioning
confidence: 99%
“…The mitochondrial oxidase is a complex of at least two components, an aGP dehydrogenase and a terminal oxidase (21). The activity of the dehydrogenase can be measured using artificial electron acceptors such as DCIP, and it is not inhibited by either Triton X-100 or benzhydroxamic acids such as SHAM.…”
Section: Assessment Of Trypanocidal Activity In Vivomentioning
African sleeping sickness is caused by Trypanosoma brucei gambiense and T. b. rhodesiense. This disease resulted in the deaths of several million people during the first half of the twentieth century (1) and continues to pose a threat of new epidemics (2). Of even more significance is the fact that animal trypanosomiasis or nagana (T. congolense, T. b. brucei, and T. vivax) makes four million square miles of the African continent unsuitable for the production of cattle and other livestock (3). The first trypanocidal agents were developed by Ehrlich and his collaborators in the early part of this century. Over the next 50 yr, drugs such as tryparsarnide, suramin, pentamidine, berenil, ethidium, Antrycide, and melarsoprol became available for use in the treatment of both sleeping sickness and nagana (4). For the past 20 yr, however, there have been no new chemotherapeutic agents introduced. Moreover, the therapeutic usefulness of the older drugs is diminishing due to the increased incidence of resistant strains (5).We have been attempting to develop new chemotherapeutic agents by elucidating biochemical differences between trypanosomes and their hosts and then designing drugs to take advantage of these differences. The present communication describes such an approach to drug development. The biochemical difference we have exploited is the inability of T. b. brucei to synthesize heine (6). As a result of this deficiency and the avid binding of heine to serum proteins in mammalian hosts, the bloodstream form of this organism has no detectable heine (S. R. Meshnick and S. Sassa, unpublished results) or hemoproteins such as cytochromes (7) or catalase (8). In a previous communication (9) we reported that the lack ofcatalase in T. b. brucei leads to an accumulation of intracellular hydrogen peroxide (H202) in these organisms, which should increase their susceptibility to killing by agents that promote the homolytic cleavage of H202 yielding hydrexy (HO.) or hydroperoxy (HOO.) radicals. Presumably, these radicals would react with unsaturated lipids and other cell constituents, thereby leading to cell destruction. Heme proved to be trypanocidal in vitro, whereas several other porphyrins showed in vivo activity (9). We ascribed this to their acting as initiators of homolytic cleavage. To enhance the efficacy of this therapeutic approach, we have attempted to determine the site of H202 production, the fate of the H202 generated, a means of increasing H202 production, and lastly, ways of rendering trypanosomes more susceptible to radical damage. J. ExP. MED.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.